Online Master of Science, Drug Discovery and Development at UNT Health

CIVM Workshop Day One: Perspective on Translating New Drug Development Tools into Regulatory Use

The Drug Discovery Process Today: How Modern Science Turns Ideas Into Medicines

Pharmacology Chapter 4 | Drug Development & Regulation: From Discovery to Clinical Trials

CGIC2024 Day 3: Patient-Focused Drug Development in the Age of Cell and Gene-Based Therapies

How does TRxA Help Bridge the Drug Development Valley of Death

Development of a New Drug from Lab to Patient Explained in 7 Steps

A Continuity of Drug Development for Diseases Across the Lifespan

Jeffrey Cummings discusses Drug Development & the Changing Alzheimer's Disease Therapeutic Landscape

C-Path Global Impact Conference 2025: Real-World Data for Drug Development

XTalks: New Era of Obesity Drug Development

CGIC2024 Day 1 Session: Characterizing Conditions with a Drug Development Mindset

Derisking Rare Disease Drug Development and Measuring Impact and Outcomes with Andrew Lo

Jane Larkindale - Why are C-Path drug development tools important in rare disease drug development?

CGIC2024 Day 3: Leveraging Learnings for the Future of Drug Development

Regulatory Pathway and Applications in Drug Development for Rare Diseases

Building Blocks of Life, AlphaFold and AI Drug Development

1.New Drug Development: Drug Discovery Phase & Pre-Clinical Studies: General Pharmacology lectures

Transforming Drug Development for Precision Medicines: A Practical Path from Evidence Generation

Diane Stephenson - Why is C-Path so important in the drug development space?

Interview - Roadblocks for drug development in CMT - Filippo Genovese & René Westhovens

C-Path Global Impact Conference 2025: Missing Voices in Neonatal Drug Development

John-Michael Sauer - How does PSTC play into drug development?

E9 – AI in Oncology: Transforming Drug Development, Medical Affairs & Patient Outcomes

CGIC2024 Day 2: A Potential New Framework to Advancing Drug Development